AI for precision medicine

Turning complex biomedical data into transformative insights

Our mission

Decoding pathology for precision medicine

We believe that AI holds the key to discover the next generation of targets and biomarkers to drastically improve how cancer and other complex diseases are diagnosed and treated. Our mission is to support the discovery and validation of these biomarkers, and to develop them into diagnostic products for global use in clinics and labs.

About our Company

Our AI models are trained with clinical-grade data from leading international institutes and are developed side-by-side with experienced pathologists.

Our patented “Explainable AI” approach allows us to overcome conventional “black box” limitations of end-to-end AI models. A proprietary cell detection and classification approach enables us to dig deep into morphology and the tumor microenvironment.

Our Technology

We are an interdisciplinary team of machine learners, data scientists, pathologists, biologists, software engineers, regulatory experts and business professionals.


We uniquely combine tech, data and science at scale to transform biomedical data into transformative insights, covering target identification, preclinical research, and translational research. We cover both histology and omics data and can leverage our own multi-modal datasets.

Clinical trials

We build robust GxP-compliant AI models from multi-lab data, for H&E, IHC and multiplex IF. We work in close collaboration with pathologists from Charité and other leading institutes, as well as regulatory experts, and can deploy with our own platform.

CDx & clinical routine

We can certify AI models with you as CDx and deploy them via third-party platforms, or our own platform for use in central labs and our partner institutions, incl. Charité Berlin. We are also working on a suite of proprietary complementary diagnostics.


Looking for an opportunity to work on something meaningful?

Be part of our diverse and fast-growing team and work on problems that really matter, while being embedded in an exciting mix of tech, scientific research and medical device development.

Our openings
In the news